|
Volumn 19, Issue 7, 2009, Pages 2018-2021
|
Synthesis of new camptothecin analogs with improved antitumor activities
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Anticancer agent; BCRP; Camptothecin analog; Topoisomerase I inhibitor
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
AMIDINE;
BREAST CANCER RESISTANCE PROTEIN;
CAMPTOTHECIN DERIVATIVE;
CH 793076;
CHO 793076;
IRINOTECAN;
RUBITECAN;
THIOUREA DERIVATIVE;
UNCLASSIFIED DRUG;
UREA DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CANCER MODEL;
CELL PROLIFERATION;
DRUG CONFORMATION;
DRUG DESIGN;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
IN VIVO STUDY;
MAXIMUM TOLERATED DOSE;
STRUCTURE ACTIVITY RELATION;
TUMOR XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
CELL LINE, TUMOR;
DNA TOPOISOMERASES, TYPE I, EUKARYOTIC;
HUMANS;
MICE;
STRUCTURE-ACTIVITY RELATIONSHIP;
TRANSPLANTATION, HETEROLOGOUS;
MUS;
|
EID: 61849162882
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.02.031 Document Type: Article |
Times cited : (18)
|
References (8)
|